HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Expression of granulocyte colony-stimulating factor and its receptor in epithelial skin tumors.

Abstract
Granulocyte colony-stimulating factor receptors (G-CSFR) have been observed on the surface of not only hematopoietic cells but also several cancer cells. In the present study, we investigated the expression of G-CSFR or G-CSF in epithelial skin tumors by immunohistochemical staining. The assessments were defined by the percentage of G-CSFR or G-CSF positive cells and expressed as G-CSFR and G-CSF scores. The G-CSFR score in SCC (77.6+/-20.0%) was significantly higher than that in Bowen's disease (BD) (51.0+/-35.6%), actinic keratosis (AK) (49.3+/-34.6%) or normal skin (30.0+/-32.1%) (P=0.0004, P=0.0003, P<0.0001, respectively). The mean G-CSF score in SCC (56.7+/-27.4%) or in BD (44.1+/-31.4%) was higher than that in normal skin (24.9+/-25.8%) (P=0.0075, P<0.001, respectively). G-CSF expression in AK (29.8+/-31.2%) was lower than that in SCC (P=0.0037). There was significant positive correlation between the G-CSFR score and the G-CSF score (gamma=0.274, P=0.0107) in skin tumors. These findings suggested that the assessment of G-CSFR expression might be associated with carcinogenesis of skin tumors.
AuthorsK Hirai, M Kumakiri, S Fujieda, H Sunaga, L M Lao, Y Imamura, K Ueda, M Fukuda
JournalJournal of dermatological science (J Dermatol Sci) Vol. 25 Issue 3 Pg. 179-88 (Apr 2001) ISSN: 0923-1811 [Print] Netherlands
PMID11240265 (Publication Type: Journal Article)
Chemical References
  • Ki-67 Antigen
  • Receptors, Granulocyte Colony-Stimulating Factor
  • Granulocyte Colony-Stimulating Factor
Topics
  • Aged
  • Bowen's Disease (metabolism)
  • Carcinoma, Squamous Cell (metabolism)
  • Granulocyte Colony-Stimulating Factor (metabolism)
  • Humans
  • Immunohistochemistry
  • Keratosis (metabolism)
  • Ki-67 Antigen (metabolism)
  • Receptors, Granulocyte Colony-Stimulating Factor (metabolism)
  • Skin (metabolism)
  • Skin Neoplasms (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: